Global Ulcerative Colitis Market by Drug Type (Anti-Inflammatory Drugs, Anti-TNF biologics, Immunosuppressant, Calcineurin Inhibitors, and Other Drug Types), Disease Type (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis), Regional Forecasts 2021-2027
The Dermatological Therapeutics market was valued at USD 30,316 million in 2020, and it is expected to reach USD 46,345 million by 2026, registering a CAGR of 8.95%, during the period.
Globally, due to high transmission rate of COVID-19, many countries a…
The Ulcerative Colitis Market is expected to register a CAGR of 5.3% during the forecast period.
COVID-19 has been a threat multiplier that affects all aspects of life. The medical and psycho-socioeconomic effects of the COVID-19 pandemic and pre-existin…